These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 9015158)

  • 1. Detection of mutagenicity in Ames test using a metalloporphyrin/oxidant model system for cytochrome P450.
    Okochi E; Kurahashi A; Mochizuki M
    Mutat Res; 1997 Jan; 373(1):99-105. PubMed ID: 9015158
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical models for cytochrome P450 as a biomimetic metabolic activation system in mutation assays.
    Inami K; Mochizuki M
    Mutat Res; 2002 Aug; 519(1-2):133-40. PubMed ID: 12160898
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activation of N-nitrosodialkylamines to mutagens by a metalloporphyrin/oxidant model system for cytochrome P450.
    Okochi E; Namai E; Ito K; Mochizuki M
    Biol Pharm Bull; 1995 Jan; 18(1):49-52. PubMed ID: 7735249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mutagenicity of aromatic amines and amides with chemical models for cytochrome P450 in Ames assay.
    Inami K; Okazawa M; Mochizuki M
    Toxicol In Vitro; 2009 Sep; 23(6):986-91. PubMed ID: 19563884
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dealkylation of N-nitrosodibenzylamine by metalloporphyrin/oxidant model systems for cytochrome P450.
    Okochi E; Mochizuki M
    Chem Pharm Bull (Tokyo); 1995 Dec; 43(12):2173-6. PubMed ID: 8582020
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A preliminary study of an iron porphyrin-iodosylbenzene system for activation of mutagens in the Ames assay.
    Salmeen IT; Foxall-VanAken S; Ball JC
    Mutat Res; 1988; 207(3-4):111-5. PubMed ID: 3282160
    [No Abstract]   [Full Text] [Related]  

  • 7. In vitro mutagenicity assays of chemical carcinogens and related compounds with Salmonella typhimurium.
    Simmon VF
    J Natl Cancer Inst; 1979 Apr; 62(4):893-9. PubMed ID: 372657
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of alpha-hydroxy N-nitrosamines in V79 Chinese hamster cells.
    Mochizuki M; Osabe M; Anjo T; Takeda K; Suzuki E; Okada M
    IARC Sci Publ; 1984; (57):715-9. PubMed ID: 6398304
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A comparison of mutation spectra detected by the Escherichia coli lac(+) reversion assay and the Salmonella typhimurium his(+) reversion assay.
    Ohta T; Watanabe-Akanuma M; Yamagata H
    Mutagenesis; 2000 Jul; 15(4):317-23. PubMed ID: 10887210
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutagenicity of nitrosamines in methyltransferase-deficient strains of Salmonella typhimurium coexpressing human cytochrome P450 2E1 and reductase.
    Cooper MT; Porter TD
    Mutat Res; 2000 Nov; 454(1-2):45-52. PubMed ID: 11035158
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of rat liver cytochrome P450 by protein restriction assessed by biochemical and bacterial mutagenicity methods [corrected].
    Cancino-Badías L; Reyes RE; Nosti R; Pérez I; Dorado V; Caballero S; Soria A; Camacho-Carranza R; Escobar D; Espinosa-Aguirre JJ
    Mutagenesis; 2003 Jan; 18(1):95-100. PubMed ID: 12473742
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oxidative transformation of 2-acetylaminofluorene by a chemical model for cytochrome P450: A water-insoluble porphyrin and tert-butyl hydroperoxide.
    Inami K; Mochizuki M
    Bioorg Med Chem; 2008 Jul; 16(14):7070-7. PubMed ID: 18586499
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic activation of heterocyclic amines and other procarcinogens in Salmonella typhimurium umu tester strains expressing human cytochrome P4501A1, 1A2, 1B1, 2C9, 2D6, 2E1, and 3A4 and human NADPH-P450 reductase and bacterial O-acetyltransferase.
    Oda Y; Aryal P; Terashita T; Gillam EM; Guengerich FP; Shimada T
    Mutat Res; 2001 May; 492(1-2):81-90. PubMed ID: 11377247
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The effects of pretreatment with cytochrome P-450 inducers and preincubation with a cytochrome P-450 effector on the mutagenicity of genotoxic carcinogens mediated by hepatic and renal S9 from two species of marine fish.
    Guobaitis RJ; Ellingham TJ; Maddock MB
    Mutat Res; 1986 Feb; 164(1):59-70. PubMed ID: 3512989
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutagenicity of cytochrome P450 2E1 substrates in the Ames test with the metabolic competent S. typhimurium strain YG7108pin3ERb5.
    Emmert B; Bünger J; Keuch K; Müller M; Emmert S; Hallier E; Westphal GA
    Toxicology; 2006 Nov; 228(1):66-76. PubMed ID: 16978761
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutagenicity and rat-liver S9 demethylation kinetics of N-nitrosomethylaniline and its ring-substituted derivatives.
    Kroeger-Koepke MB; Andrews AW; Kupper RJ; Koepke SR; Michejda CJ
    Mutat Res; 1981 Aug; 89(4):255-67. PubMed ID: 7027031
    [TBL] [Abstract][Full Text] [Related]  

  • 17. S9 induction by the combined treatment with cyclohexanol and albendazole.
    Escobar-Garcia D; Camacho-Carranza R; Pérez I; Dorado V; Arriaga-Alba M; Espinosa-Aguirre JJ
    Mutagenesis; 2001 Nov; 16(6):523-8. PubMed ID: 11682644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Modulation of aromatic amine mutagenicity in Salmonella typhimurium with rat-liver 9000 g supernatant or monolayers of rat hepatocytes as an activation system.
    Holme JA; Haug LT; Dybing E
    Mutat Res; 1983 Apr; 117(1-2):113-25. PubMed ID: 6339903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of human cytochrome P450 (CYP) in the metabolic activation of N-alkylnitrosamines: application of genetically engineered Salmonella typhimurium YG7108 expressing each form of CYP together with human NADPH-cytochrome P450 reductase.
    Fujita K; Kamataki T
    Mutat Res; 2001 Nov; 483(1-2):35-41. PubMed ID: 11600130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pH-dependent response of Salmonella typhimurium TA100 to mutagenic N-nitrosamines.
    Negishi T; Hayatsu H
    Mutat Res; 1980 Nov; 79(3):223-30. PubMed ID: 7012604
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.